MORRISTOWN, N.J. Oct. 17, 2012– New data presented today at the American Association of Pharmaceutical Sciences Annual Meeting and Exposition show that plant-based capsules made from Hypromellose ...
This paper discusses what causes cross-linking, how cross-linking is addressed with addition of enzymes, and consideration for occasional high results that can be obtained during release testing. A ...
The bioavailability of some insoluble drugs is enhanced when they are dissolved in the solubilizing agent macrogol 400, although conventional hard capsules cannot tolerate the agent. This article ...
Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test. Teva is voluntarily recalling a single lot ...
(RTTNews) - Mahwah, New Jersey-based Glenmark Pharmaceuticals Inc., USA is recalling 114 batches of Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K citing failed dissolution, ...
American Health Packaging on behalf of BluePoint Laboratories is voluntarily recalling 21 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, to the consumer level. The ...
Zydus announced a voluntary recall of Venlafaxine HCl ER 75mg and 150mg Capsules due to an out of specification dissolution result in a retained sample. Zydus announced a voluntary recall of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results